物理治疗干预在吉兰·巴雷综合征的有效性:一个案例报告
Ishwari Gawande1, Aditi Akhuj1, Snehal Samal1
1Department of Neuro-Physiotherapy, Ravi Nair Physiotherapy College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|February 12, 2024
概括
吉兰-巴雷综合征 (GBS) 是一种神经疾病,可由B组链球菌和Campylobacter jejuni.等细菌引发. 早期康复可显著改善受影响患者的运动控制和生活质量.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 吉兰-巴雷综合征 (GBS) 呈现出渐进的,上升的软弱,低和运动障碍.
- 关键的细菌触发物包括B组链球菌 (Streptococcus agalactia) 和Campylobacter jejuni. 这两种.
- GBS包括急性运动轴突神经病变 (AMAN),急性运动和感觉轴突神经病变 (AMSAN),急性炎症性脱髓化神经病变 (AIDP) 和米勒-费舍尔综合征 (MFS) 等变体.
研究的目的:
- 描述一个年轻患者的吉林-巴雷综合征病例.
- 突出康复在管理GBS中的作用.
- 评估治疗方案对患者结果的有效性.
主要方法:
- 一个20岁的女性呈现GBS症状 (虚弱,发烧,下肢疼痛) 的案例研究.
- 为了评估结果,使用了休斯GBS残疾量表和功能独立度量表.
- 实施了一个全面的康复协议.
主要成果:
- 患者经历了普遍的虚弱,发烧和下肢疼痛,与GBS一致.
- 治疗和康复对健康和生活质量产生了积极影响.
- 康复方案导致改善姿势,运动控制和预防次要障碍.
结论:
- 康复对于管理吉兰-巴雷综合征至关重要.
- 有效的治疗方案可以显著减少患者的挑战,并增强功能恢复.
- 早期干预和量身定制的康复可以改善运动控制和患者的整体幸福感.
更多相关视频
04:43Author Spotlight: Advancing Upper Limb Rehabilitation in Patients with Right Hemisphere Damage Using Assisted Active Exercise
Published on: February 9, 2024
1.1K
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023
1.9K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:15Myasthenia Gravis: Diagnostic Tests
840
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
840